ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

New Model Provides Better Estimate of Breast Cancer Risk in Black Women.

November 30, 2007

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991

Women’s Health Initiative: Cutting Fat Has Small Effect On Breast Cancer Risk

February 24, 2006

Lung Cancer Deaths Level Off In White Men, NCI Study Says

January 3, 1992

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002

Virus Program Scientific Activities Report Concluded

August 22, 1975